Drug intelligence / Profile preview

Restoranail

Development stage: Unknown
Lead developer: Alto Pharmaceuticals
Modality: Small Molecules
Administration: Topical

Overview

Restoranail is a topical nail care solution developed and marketed by Alto Pharmaceuticals, primarily in the Canadian market. The formulation contains 16% poly-ureaurethane, which acts as a film-forming agent. When applied to the nail, it creates a uniform, flexible, waterproof, and breathable barrier. This physical barrier is designed to manage nail dystrophy (brittle, cracked, or damaged nails) and treat mild to moderate onychomycosis by inhibiting the growth of dermatophytes through environmental modification rather than pharmacological absorption. It is an over-the-counter (OTC) product that is applied once daily and allows for the concurrent use of nail polish.

Brand names: Restoranail
Other names: Restoranail (nail care)

Beyond the preview

Go deeper on Restoranail.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Restoranail.

Explore the full profile